Geode Capital Management’s Plus Therapeutics PSTV Stock Holding History

Geode Capital Management’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$328K	Buy	80,653 +24,541	+44%	+$186K	﹤0.01%	3734
2025 Q4	$719K	Buy	56,112 +23,582	+72%	+$356K	﹤0.01%	3470
2025 Q3	$556K	Buy	32,530 +30,483	+1,489%	+$374K	﹤0.01%	3582
2025 Q2	$17.8K	Sell	2,047 -235	-10%	-$3.07K	﹤0.01%	4376
2025 Q1	$54.2K	Sell	2,282 -44	-2%	-$1.23K	﹤0.01%	4185
2024 Q4	$66.9K	Buy	2,326 +155	+7%	+$4.96K	﹤0.01%	4191
2024 Q3	$79.2K	Buy	2,171 +305	+16%	+$12K	﹤0.01%	4163
2024 Q2	$68.6K	Buy	1,866 +695	+59%	+$34.1K	﹤0.01%	4219
2024 Q1	$52.8K	Buy	1,171 +109	+10%	+$5.27K	﹤0.01%	4306
2023 Q4	$47.5K	Hold	1,062	–	–	﹤0.01%	4363
2023 Q3	$35.6K	Buy	1,062 +382	+56%	+$20.5K	﹤0.01%	4508
2023 Q2	$34.4K	Hold	680	–	–	﹤0.01%	4583
2023 Q1	$74K	Sell	680 -8	-1%	-$1.08K	﹤0.01%	4431
2022 Q4	$81K	Sell	688 -1	-0.1%	-$159	﹤0.01%	4464
2022 Q3	$115K	Hold	689	–	–	﹤0.01%	4514
2022 Q2	$139K	Hold	689	–	–	﹤0.01%	4443
2022 Q1	$258K	Hold	689	–	–	﹤0.01%	4254
2021 Q4	$271K	Hold	689	–	–	﹤0.01%	4344
2021 Q3	$493K	Buy	689 +340	+97%	+$259K	﹤0.01%	4033
2021 Q2	$334K	Buy	+349	New	+$315K	﹤0.01%	4121
2019 Q3	–	Sell	-1	Closed	-$3K	–	4228
2019 Q2	$3K	Hold	1	–	–	﹤0.01%	4204
2019 Q1	$4K	Hold	1	–	–	﹤0.01%	4125
2018 Q4	$4K	Hold	1	–	–	﹤0.01%	4140
2018 Q3	$6K	Hold	1	–	–	﹤0.01%	4118
2018 Q2	$24K	Hold	1	–	–	﹤0.01%	4035
2018 Q1	$47K	Hold	1	–	–	﹤0.01%	3956
2017 Q4	$49K	Hold	1	–	–	﹤0.01%	3925
2017 Q3	$62K	Hold	1	–	–	﹤0.01%	3905
2017 Q2	$188K	Buy	+1	New	+$202K	﹤0.01%	3709
2017 Q1	–	Hold	0	–	–	–	3836
2016 Q4	–	Hold	0	–	–	–	3805
2016 Q3	–	Hold	0	–	–	–	3758
2016 Q2	–	Hold	0	–	–	–	3730
2016 Q1	–	Hold	0	–	–	–	3648
2015 Q4	–	Hold	0	–	–	–	3738
2015 Q3	–	Hold	0	–	–	–	3493
2015 Q2	–	Hold	0	–	–	–	3314
2015 Q1	–	Hold	0	–	–	–	3173
2014 Q4	–	Hold	0	–	–	–	3637
2014 Q3	–	Hold	0	–	–	–	3505
2014 Q2	–	Hold	0	–	–	–	2959
2014 Q1	–	Hold	0	–	–	–	2887
2013 Q4	–	Hold	0	–	–	–	2916
2013 Q3	–	Hold	0	–	–	–	2834
2013 Q2	–	Hold	0	–	–	–	2770

Other funds holding PSTV

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management's PSTV Position: Q1 2026 in Review

Geode Capital Management increased its Plus Therapeutics (PSTV) stake by 44% in Q1 2026, buying an estimated $186K and bringing the position to 80,653 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #3734.

Geode Capital Management first reported a position in PSTV in Q2 2017 and has held it in 29 quarters since. The position peaked at $719K in Q4 2025. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.

Geode Capital Management held 80,653 shares of Plus Therapeutics worth $328K as of Q1 2026.
Geode Capital Management bought 24,541 Plus Therapeutics shares in Q1 2026, an estimated $186K.
Plus Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3734 holding.
Geode Capital Management first reported a position in Plus Therapeutics in Q2 2017 and has held it in 29 quarters since.
Geode Capital Management's Plus Therapeutics position peaked at $719K in Q4 2025.
23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.